SHPMF (Shanghai Pharmaceuticals Holding Co) Marketable Securities: $1,437 Mil (As of Mar. 2026)


SHPMF Shanghai Pharmaceuticals Holding Co Ltd SHPMF
73 GF Score
Price $1.46
GF Value $1.81
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co Marketable Securities?

Shanghai Pharmaceuticals Holding Co SHPMF -4.58% 73 Marketable Securities is $1,437 Mil as of Mar. 2026. GuruFocus rates SHPMF with a GF Score™ of 73/100 and a GF Value™ of $1.81. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Shanghai Pharmaceuticals Holding Co's Marketable Securities for the quarter that ended in Mar. 2026 was $1,437 Mil.

Shanghai Pharmaceuticals Holding Co's annual Marketable Securities declined from Dec. 2023 ($1,422 Mil) to Dec. 2024 ($1,186 Mil) but then increased from Dec. 2024 ($1,186 Mil) to Dec. 2025 ($1,471 Mil).

Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Shanghai Pharmaceuticals Holding Co Marketable Securities Related Terms

Shanghai Pharmaceuticals Holding Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co Marketable Securities Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1,378.94 1,421.83 1,185.73 1,471.06

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,222.73 1,170.53 1,097.25 1,471.06 1,437.06
SHPMF
73GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMF
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $1,437 Mil mean?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a Marketable Securities of $1,437 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors.
Is Shanghai Pharmaceuticals Holding Co's Marketable Securities too high?
Shanghai Pharmaceuticals Holding Co's current Marketable Securities is $1,437 Mil. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's Marketable Securities compare to MCK and CAH?
Shanghai Pharmaceuticals Holding Co's Marketable Securities of $1,437 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Distribution company?
A good Marketable Securities depends on the Medical Distribution industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current Marketable Securities is $1,437 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Shanghai Pharmaceuticals Holding Co (SHPMF) has a current Marketable Securities of $1,437 Mil. The stock's GF Value™ is $1.81, compared to a current price of $1.46 — trading 19.3% below its estimated fair value. The current Marketable Securities is $1,437 Mil. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMF), the current Marketable Securities is $1,437 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $1.46 is trading 19.3% below its estimated GF Value™ of $1.81.

Key valuation signals for SHPMF:

  • Marketable Securities: $1,437 Mil
  • GF Value™: $1.81 vs. price of $1.46 (19.3% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the SHPMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
73GF Score

Get the complete analysis for SHPMF

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.46
Price
$1.81
GF Value